Corticosteroid

The use of corticosteroids improved the odds that adults who are critically ill with COVID-19 would survive, according to data from four studies recently published in JAMA.

Corticosteroids with standard treatment for patients with Kawasaki disease reduced the risk for coronary artery abnormalities and treatment failure, researchers found.

The FDA has approved triple inhaled therapy for maintenance treatment of patients with COPD, according to a press release from AstraZeneca.

Among patients with sarcoidosis, higher medication adherence was associated with improved health-related quality of life, with Black patients more likely to report medication nonadherence, according to observational data published in Chest.

Learning Objectives:

Local intraoperative corticosteroids administered after anterior cervical discectomy and fusion may be effective in reducing swallowing difficulties, according to published results.

Triple inhaled therapy with twice-daily budesonide, at two doses, glycopyrrolate and formoterol reduced the rate of moderate or severe COPD exacerbations compared with two dual-combination therapies, according to data from the ETHOS trial.

Rapid corticosteroid tapering over 2 weeks was safe in patients with relapsed or refractory multiple myeloma who received subcutaneous daratumumab, according to findings presented at ASCO20 Virtual Scientific Program.

Masitinib significantly reduced asthma exacerbations in patients with severe asthma uncontrolled by oral corticosteroids compared with placebo treatment, according to new data.

Maternal antenatal corticosteroid treatment exposure appeared significantly associated with pediatric mental and behavioral disorders, according to results of a population-based cohort study published in JAMA.